Introduction
Myasthenia gravis (MG)is an autoimmunedisorder of the neuromuscular junction (1) . The muscle weakness reflects the loss of functional acetylcholine receptor (AcR) at the postsynaptic membrane of the neuromuscular junction by autoantibody to AcR. It has been reported that patients with autoimmune disease often show an association of MG (1, 2) .
Wetreated a patient with MGand associated mixed connective tissue disease (MCTD) (3) (4) (5) . Since we found that the association of MCTD and MGis rare, we present the clinical features of the patient and review previous case reports concerning the association of MGand various connective tissue diseases (CTD) .
Case Report
In July 1992, a 41-year-old Japanese womanvisited our institute hospital because of weakness and disorientation. She had experienced 3 instances of spontaneous abortion, Raynaud' s phenomenon and photosensitivity over the previous 20 years.
Subarachnoid bleeding due to the rupture of a cerebral aneurysm occurred in January 1988. She underwent a clipping operation and ventriculo-peritoneal shunt. In June 1991, she noticed disorientation and muscle weakness with gait disturbance.
She complained of a mild arthralgia without joint deformity as well as a mild dryness of the eyes and mouth. She had photosensitivity, sclerodactylia as well as swollen hands, Raynaud's phenomenon, and pigmentation in the lower extremities. Nostruma was observed. Her consciousness was that of a stupor and disorientation was also observed. The tendon reflexes and sensations werenormal. Muscleweaknesswith ataxic gait and ptosis of the eyelids were observed, but neither muscle atrophy nor diplopia were found. A CT of the brain disclosed a deformity of the skull due to the previous operation for subarachnoid bleeding and there were two areas of calcification around the left sylvian fissure. A decrease in the blood flow around the calcification in the brain was detected by single photon emission computed tomography, suggesting that the disorientation and gait disturbance were morelikely due to a disturbed cerebral blood flow than to antiphospholipid syndrome. A plain X-ray and CTof the chest and abdomenshowedneither any tumor or thymusenlargement. In addition, neither fibrosis of the lung nor any retention of fluid was present. A marked decrease in the % VC (26.9%) was seen, but the % FEV1 (90.6%) and DLCO(34.5 ml/min) were within the normal range. A decreased motility of the esophagus was shown by barium esophagography, but no distension was observed. Noosteopenia or joint destruction was observed in the plain X-ray films. Electromyography (EMG)showed myopathic potentials with a waning phenomenon. A muscle biopsy of the quadriceps muscle showed diffuse and marked atrophy of the myofibers with a reduction in its diameter. Cell infiltration and muscle necrosis were absent. x2,560 serum dilution (speckled pattern) and anti-DNA antibody was 10.7 IU/ml (normal; less than 10 IU/ml). The antibody to extractable nuclear antigen (nENA) and RNaseresistant ENA(rENA) measured by passive hemagglutination were x5 12,000 and x4, 100 serum dilution, respectively. Antiribonucleoprotein (RNP) antibody and anti-Sm antibody detected by Ouchterlony's double diffusion were xl28 and x4 serum dilution, respectively. Antibody to SSAwas positive at x64 serum dilution by Ouchterlony's double diffusion, but the anti-SSB was negative. Antibodies to Scl-70, centromere, Jo-1 , thyroglobulin, microsome, smooth muscle and mitochondria were negative. Direct Coombs' test and cold agglutinin (x5 12) were positive. Rheumatoid factor was positive at 121 IU/ml (normal; less than 1 8 IU/ml). Antibody to AcR was positive (13 nMA;normal <0.6) (6). Anti-cardiolipin antibody of IgG class was positive at 1.6 EIA unit (normal; less than 1.0 U) and platelet-associated IgG (PAIgG) was positive (13 1.9 ng/107 of platelets; normal 9.0-25.0), but STS and lupus anticoagulant were negative. In addition, the antibody to human Tlymphocytotropic virus I (HTLV-I) was negative.
The diagnosis ofMCTD was made according to the diagnostic criteria proposed by Sharp and the Japan Ministry of Health and CTDtotaled 3 for PSS, about 80 for PM/DM, about 50 for SLE and 10 for SjS (Table 2 ) (12-23). However, none of them fulfilled the diagnostic criteria for MCTDand it is thus concluded that the association ofMCTDand MGis rare. It has been reported that the most commonCTDassociated with MGis rheumatoid arthritis (RA), but the pathogenesis for the greater part of the patients was ascribed to the administered Dpenicillamine (1, 2, 6, 24) . D-penicillamine has been demonstrated to bring about an autoimmune phenomenon including MG (6, 24) . However, none of the 3 MCTDpatients was administered D-PC. Consequently, we could not find any obvious pathological basis for the association of MGand MCTD. However, we would like to discuss the importance of the association of SjS, since the characteristics of our MCTDpatient, including the demonstration of various autoantibodies and sicca complex, are the same as those for SjS. The association of SjS with MCTD has ranged from 7% to 48% (3, 25) , from40% to 98% in SLE (26-29), and 17% to 88% in PSS (30-33) in recent reports. We also showed that positive sialectasis was found in 82%of the patients with MCTD(1 1). Lindahl et al showed aprevalence as high as 73 % (8/1 1 ) of positive lymphocytic infiltration in labial salivary gland biopsies of the patients with MG(34). These findings suggest that the previous authors did not pay much attention to the presence of SjS because of a lack of symptoms even in the presence of salivary gland damage. It is thus reasonable to speculate that the unnoticed association of SjS in previously reported cases should have been much more frequent than what was actually described. Patients with SjS are reported to have a decrease in suppressor-inducer T-cells in the peripheral blood and an increase in immunoglobulin secreting B-cells in the saliva (35, 36), which were responsible for the polyclonal activation ofB-cells and the presence of polyspecific antibodies to self organs. The affinity of antibodies produced by the polyclonal activation of B-cells is reported to be low and polyspecific and MGpatients associated with malignancies are generally responsive to drug therapy such as corticosteroid administration (1, 35, 36) . In this sense, it should be noted that the administration ofprednisolone in our patient was markedly effective. In addition, an immediate decrease of autoantibody production including anti-AcR antibody following corticosteroid administration may suggest the participation of the polyclonal activation of B-cells. Such abnormalities might have resulted in the generation of autoantibodies to the AcR, phospholipid, and blood cells. None of the 3 MCTD patients showed either any obvious thymus enlargement or tumors, but the correlations between CTDassociated MGand thymus abnormalities have been previously discussed by many authors (1, 9, 13-16, 19, 20) . Based on the above findings, we thus speculate that thymus abnormalities may have played a role in the present case, too. Wetherefore conclude that one of the pathological bases for the coexistence of MGand MCTD is likely immune system disorders, which might manifest themselves as SjS with exocrine gland damage and polyclonal B-cell activation.
